Search and Filter
Results per Page:
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Travel writer takes an unexpected cancer journey
Writer and TV host Rick Steves deals with a prostate cancer diagnosis and offers hope to others
Polygenic risk scores and prostate cancer
New research shows genetic risk scores could help distinguish who can cut back on ‘active surveillance’
10 years in, HICOR’s efforts boost cancer care’s value
Fred Hutch’s Value in Cancer Care Initiative celebrates a decade of data and crucial collaborations between providers, payers and patients
Finding a new way to break the supply chain fueling advanced prostate cancer
Fred Hutch researcher wins a $1M grant for a London-Seattle collaboration to find new therapies for drug-resistant prostate cancer
Fred Hutch expands its research capacity in South Lake Union
Three new buildings will boost recruitment and strengthen science
A quarter century of lifesaving discoveries in prostate cancer
Pacific Northwest Prostate Cancer SPORE insights have transformed patient care and understanding of prostate cancer biology, supported drug discovery worldwide
Bridging the gap between cancer drug target and cancer drug
Fred Hutch RNA-translation expert Dr. Andrew Hsieh receives Harrington Scholar-Innovator Award to develop experimental compound into anti-cancer drug
AACR 2024: Liquid biopsies, better treatments and baseball
Fred Hutch scientist throws out first pitch, welcomes new AACR president at San Diego cancer conference
Fred Hutch launches rare cancer research effort
New TRACER initiative aims to accelerate advances through multidisciplinary collaboration and innovative approaches
For 22 years, Drew Bouton has lived with metastatic prostate cancer
Participating in clinical trials, he has helped define the standard of care
Knowing your risk for inherited cancers matters
Take advantage of year-end family gatherings to discuss health history
New projects advance health equity research
Two $1M grants support efforts to pinpoint novel prostate cancer biomarkers, improve clinical trial enrollment and inclusion
How do we increase equity in cancer care?
HICOR’s Value in Cancer Care Summit brings together stakeholders to discuss barriers, pain points and solutions
BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave Fellow
In memory of runner Gabe Grunewald, research at Fred Hutch will inform new treatments for rare and aggressive cancers
Cancer care: From ‘sledgehammer’ to precision cellular therapy
AACR progress report: new immunotherapies improve outcomes, but access to care and clinical trials for many still lags
Focusing on prostate cancer treatment without surgery
HIFU therapy offers alternative for one-third of patients, including Bothell’s Ken Cleary
RNA stability may play a role in prostate cancer
New research links mutations in RNA region that helps regulate protein production to progression and drug resistance
Improving immunotherapy for advanced prostate cancer
Preclinical work identifies better target and recruits more immune cells to make CAR-T therapy work for solid tumors
New computational tools widen horizons for liquid biopsies
Methods allow scientists to use gene regulation patterns to detect cancer subtype in cell-free DNA